Hayat Pharmaceutical Industries Co (AMM:HPIC) Total Receivables: JOD12.49 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
46 GF Score
Price JOD3.22
! 8 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co Total Receivables?

Hayat Pharmaceutical Industries Co AMM:HPIC 46 Total Receivables is JOD12.49 Mil as of Jun. 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 46/100. The stock has 8 warning signs investors should review.

Hayat Pharmaceutical Industries Co's Total Receivables for the quarter that ended in Jun. 2026 was JOD12.49 Mil.

Hayat Pharmaceutical Industries Co Total Receivables Related Terms

Hayat Pharmaceutical Industries Co Total Receivables Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co Total Receivables Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.50 9.49 9.81 10.91 11.95

Hayat Pharmaceutical Industries Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.84 12.53 11.95 11.45 12.49
AMM:HPIC
46GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hayat Pharmaceutical Industries Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of JOD12.49 Mil mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Total Receivables of JOD12.49 Mil as of Jun. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Hayat Pharmaceutical Industries Co and its competitors.
Is Hayat Pharmaceutical Industries Co's Total Receivables too high?
Hayat Pharmaceutical Industries Co's current Total Receivables is JOD12.49 Mil. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Total Receivables compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's Total Receivables of JOD12.49 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Hayat Pharmaceutical Industries Co and its competitors. Hayat Pharmaceutical Industries Co's current Total Receivables is JOD12.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a current Total Receivables of JOD12.49 Mil. The current Total Receivables is JOD12.49 Mil. Hayat Pharmaceutical Industries Co's overall GF Score™ is 46/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Total Receivables is JOD12.49 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
46GF Score

Get the complete analysis for AMM:HPIC

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.22
Price